The DBP phenotype Gc-1f/Gc-1f is associated with reduced risk of cancer. The Tromsø study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Jorde, Rolf ^a,b,c   Schirmer, Henrik ^a   Wilsgaard, Tom ^a   Mathiesen, Ellisiv Bøgeberg ^a,b   Njølstad, Inger ^a   Løchen, Maja Lisa ^a   Joakimsen, Ragnar Martin ^a,b   Grimnes, Guri ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; DNA; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; CARRIER PROTEIN; VITAMIN D; VITAMIN D BINDING PROTEIN 1, PRIMATE; VITAMIN D BINDING PROTEIN 2, PRIMATE;

ADULT; ARTICLE; BODY HEIGHT; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DEATH; FEMALE; GENDER; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HIP CIRCUMFERENCE; HOMOZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PHENOTYPE; PROSTATE CANCER; RISK REDUCTION; VITAMIN BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BLOOD; GENETICS; METABOLISM; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; NORWAY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84930646309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126359     Document Type: Article

References (40)

1. Cooke NE, Willard HF, David EV, George DL (1986) Direct regional assignment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorphism. Hum Genet 73: 225-229. PMID: 3015768
2. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG (1986) Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 63: 954-959. PMID: 3745408
3. Van Baelen H, Bouillon R, De Moor P (1978) The heterogeneity of human Gc-globulin. J Biol Chem 253: 6344-6345. PMID: 79572
4. Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30: 445-456. doi: 10.1002/cbf.2835 PMID: 22528806
5. Arnaud J, Constans J (1993) Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92: 183-188. PMID: 8370586
6. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281. PMID: 17634462
7. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, et al. (2011)Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26: 1609-1616. doi: 10.1002/jbmr.387 PMID: 21416506
8. Johnsen MS, Grimnes G, Figenschau Y, Torjesen PA, Almås B, Jorde R (2014) Serum free and bioavailable 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand J Clin Lab Invest 74: 177-183. doi: 10.3109/00365513.2013.869701 PMID: 24383929
9. Williams MH, Van Alstyne EL, Galbraith RM (1988) Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein). Biochem Biophys Res Commun 153: 1019-1024. PMID: 3134016
10. Meier U, Gressner O, Lammert F, Gressner AM (2006) Gc-globulin: roles in response to injury. Clin Chem 52: 1247-1253. PMID: 16709624
11. McVoy LA, Kew RR (2005) CD44 and annexin A2 mediate the C5a chemotactic cofactor function of the vitamin D binding protein. J Immunol 175: 4754-4760. PMID: 16177123
12. Nagasawa H, Sasaki H, Uto Y, Kubo S, Hori H (2004) Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein. Anticancer Res 24(5C): 3361-3366. PMID: 15515432
13. Schneider GB, Grecco KJ, Safadi FF, Popoff SN (2003) The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr 13: 277-284. PMID: 14696974
14. Nagasawa H, Uto Y, Sasaki H, Okamura N, Murakami A, Kubo S, et al. (2005) Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res 25(6A): 3689-3695. PMID: 16302727
15. Speeckaert MM, Speeckaert R, van Geel N, Delanghe JR (2014) Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem 63: 1-57. PMID: 24783350
16. Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, et al. (2013) Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci 50: 1-22. doi: 10.3109/10408363.2012.750262 PMID: 23427793
17. Thelle DS, Førde OH, Try K, Lehmann EH (1976) The Tromsø heart study. Methods and main results of the cross-sectional study. Acta Med Scand 200: 107-118. PMID: 785953
18. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I (2012) Cohort profile: the Tromso Study. Int J Epidemiol 41: 961-967. doi: 10.1093/ije/dyr049 PMID: 21422063
19. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njølstad I, et al. (2012) Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One 7: e37295. doi: 10.1371/journal.pone.0037295 PMID: 22649517
20. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, et al. (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163: 339-348. doi: 10.1530/EJE-10-0150 PMID: 20479012
21. Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K (2007) Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov 4: 15. PMID: 18053196
22. Song YH, Naumova AK, Liebhaber SA, Cooke NE (1999) Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res 9: 581-587. PMID: 10400926
23. Lettre G (2009) Genetic regulation of adult stature. Curr Opin Pediatr 21: 515-522. doi: 10.1097/MOP.0b013e32832c6dce PMID: 19455035
24. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23: 313-342. PMID: 12192740
25. Njølstad I, Arnesen E, Lund-Larsen PG (1996) Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study. Circulation 94: 2877-2882. PMID: 8941116
26. Jousilahti P, Tuomilehto J, Vartiainen E, Eriksson J, Puska P (2000) Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle- aged men and women in Finland. Am J Epidemiol 151: 1112-1120. PMID: 10873136
27. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, et al. (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77: 15-22. PMID: 15868280
28. Shui I, Giovannucci E (2014) Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 810: 33-51. PMID: 25207359
29. Moukayed M, Grant WB (2013) Molecular Link between Vitamin D and Cancer Prevention. Nutrients 5: 3993-4021. doi: 10.3390/nu5103993 PMID: 24084056
30. Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ 349: g6330. doi: 10.1136/bmj.g6330 PMID: 25406188
31. Bolland MJ, Grey A, Gamble GD, Reid IR (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2: 307-320. doi: 10.1016/S2213-8587(13)70212-2 PMID: 24703049
32. Negri AL (2006) Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex. Nephrology 11: 510-515. PMID: 17199789
33. Abboud M, Gordon-Thomson C, Hoy AJ, Balaban S, Rybchyn MS, Cole L, et al. (2014) Uptake of 25-hydroxyvitamin D by muscle and fat cells. J Steroid Biochem Mol Biol 144 Pt A: 232-236. doi: 10.1016/j.jsbmb.2013.10.020 PMID: 24189546
34. Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, et al. (2010) Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One 5: e13428. doi: 10.1371/journal.pone.0013428 PMID: 20976141
35. Yamamoto N, Suyama H, Yamamoto N (2008) Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Transl Oncol 1: 65-72. PMID: 18633461
36. Thyer L, Ward E, Smith R, Fiore MG, Magherini S, Branca JJ, et al. (2013) A novel role for a major component of the vitamin D axis: vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages. Nutrients 5: 2577-2589. doi: 10.3390/nu5072577 PMID: 23857228
37. Zhou L, Zhang X, Chen X, Liu L, Lu C, Tang X, et al. (2012) GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med 5: 72-79. PMID: 22328951
38. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. (2008) The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 17: 1339-1343. doi: 10.1158/1055-9965.EPI-08-0162 PMID: 18559548
39. Wilson RT, Bortner JD Jr, Roff A, Das A, Battaglioli EJ, Richie JP Jr, et al. (2014) Genetic and environmental influences on plasma vitamin D-binding protein concentrations. Transl Res pii: S1931-5244 (14)00280-1. doi: 10.1016/j.trsl.2014.08.003. [Epub ahead of print]
40. Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, et al. (2009) Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 85: 85-93. doi: 10.1007/s00223-009-9251-9 PMID: 19488670